Advanced systemic mastocytosis (advSM) is a rare and serious form of systemic mastocytosis, a blood disorder that involves the overproduction of mast cells. Mast cells are a type of white blood cell ...

MILAN — The landscape of hematologic malignancies is shifting rapidly, in part due to the evolving significance of measurable (formerly "minimal") residual disease (MRD). Once confined to the realm of ...

Olorofim has the potential to be particularly beneficial to patients with hematologic malignancies infected with Invasive ...

Please provide your email address to receive an email when new articles are posted on . A multicenter research effort yielded findings that may allow for more effective and personalized treatment of ...

Beyond the Trials: Real-World Considerations for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Study design, end points, and statistical analysis for REACH2 (ClinicalTrials.gov identifier ...

Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, ...

Patients with hematologic malignancies have an increased risk for cardiovascular disease (CVD) compared with the general population.

The MarketWatch News Department was not involved in the creation of this content.-- The agreement aims to expand access to the therapy in Brazil; -- The Technology is for patients ...

Stable production of anti-sickling adult hemoglobin (HBAT87Q) and elimination or significant reduction of vaso-occlusive events sustained through last follow-up for all evaluable patients (n=38), ...

SOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation ...